Meet Critical FDA Deadlines with 24/5 Rapid Submission Support!
When every hour matters, Freyr’s urgent FDA submissions team delivers in less than 24 hours — keeping your compliance on track and your therapies on time. Backed by automation, accuracy, and global expertise, we help you meet critical deadlines and keep your U.S. launch on track—without compromising compliance.
Talk to Our Rapid Response Team
Fast-Track My FDA Filing
Every Hour Counts — Here’s How We Deliver
< 2 Hours
Acknowledgement Time
24-Hours
Turnaround for Urgent Submissions
3000+
Urgent Submissions Delivered Annually
Global Red Alert Team
Based in US, Colombia & India
Freyr’s Complete Rapid-Response Regulatory Support
IND safety reports
NDA/BLA supplements and compliance submissions
Fast-track designations
24/5 Dedicated Team with Global Coverage
Frequently Asked Questions
Freyr's Rapid Response Team Support Service is a specialized, fast-track service that helps life sciences companies meet critical FDA deadlines. Our 24/5 global publishing team delivers urgent IND, NDA, and BLA compliance submissions in less than 24 hours, ensuring your compliance stays on schedule — even under tight timelines.
Our Rapid Response Team supports a wide range of urgent FDA filings, including:
- IND safety reports
- NDA/BLA supplements and amendments
- Fast-track designation filings
- Compliance and annual reports
- Promotional and ad-promo material submissions
All submissions are compiled, validated, and published using FDA-compliant eCTD automation tools.
Even in high-speed scenarios, Freyr maintains 99.8% accuracy through AI-powered QC automation. Every submission undergoes multi-level validation checks — including hyperlinks, bookmarks, metadata, and XML review — ensuring full compliance with FDA eCTD standards and 21 CFR Part 11 requirements.
Our Rapid Response Team acknowledges all urgent requests within 2 hours and begins publishing immediately. Depending on submission complexity, the complete eCTD package is delivered to the FDA within 24 hours or less.
Freyr’s Rapid Response Team operates 24/5 across multiple time zones — with publishing hubs in the United States, Colombia, and India. This overlapping coverage ensures real-time collaboration, continuous handovers, and no downtime, even for after-hours requests.
Freyr’s Rapid Response Team supports companies in pharmaceuticals, biologics, and medical devices, as well as biotech innovators. Our solutions are ideal for sponsors handling fast-track programs, rolling submissions, or compliance-driven amendments requiring same-day delivery.
Yes. Freyr manages end-to-end FDA submission lifecycles, including original IND/NDA/BLA filings, post-approval variations, annual reports, and urgent compliance submissions — all with guaranteed speed, accuracy, and traceability.
Freyr is among the few global providers offering dedicated Rapid Response coverage 24/5 with a three-shift operational model, backed by AI automation and regional publishing experts. This ensures faster turnaround, cost efficiency, and zero compromise on compliance quality.
Yes. Freyr provides rapid submission support across regions, including the U.S., EU, Canada, Japan, and APAC markets. Our experts are trained in region-specific eCTD standards and local health authority requirements to ensure compliance worldwide.